1 / 29

Presenter: Juan Mo

Presenter: Juan Mo. Learning objectives. What is gene therapy? What is a Dox-regulatable system and how can gene expression be regulated by Dox? What is the difference between TetON and TetOFF? What is the role of RPE65? What is electroretinography (ERG)?. Introduction.

alice
Télécharger la présentation

Presenter: Juan Mo

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Presenter: Juan Mo

  2. Learning objectives • What is gene therapy? • What is a Dox-regulatable system and how can gene expression be regulated by Dox? • What is the difference between TetON and TetOFF? • What is the role of RPE65? • What is electroretinography (ERG)?

  3. Introduction • Gene therapy: the use of DNA as a pharmaceutical agent to treat disease. • Parameters when choosing a gene therapy vector: (1) size limitations for insertion of transgenes, (2) purity and titer of the vector, (3) transduction efficiency, (4) ability to infect dividing and/or quiescent cells, (5) long-term expression of transgenes, (6) integration into the host genome, (7) the need for cell-type specificity or targeted delivery, (8) vector-associated toxicity and immunogenicity.

  4. Virus Vector • Adenovirus • Adeno-associated virus • Herpes simplex virus type 1 • retrovirus

  5. Regulatory System • Doxycycline: is a member of the tetracycline antibiotics group. Doxycycline is used in "Tet-on" and "Tet-off" tetracycline-controlled transcriptional activation to regulate transgene expression in organisms and cell cultures. tTA (Tet-off) or rtTA (Tet-on) : Tet-controlled transcriptional activator TRE: tetracycline response element

  6. tTA (Tet-off) or rtTA (Tet-on) : Tet-controlled transcriptional activator Tet-OFF Regulatable Switch TRE: tetracycline response element

  7. Tet-ON Regulatable Switch tTA (Tet-off) or rtTA (Tet-on) : Tet-controlled transcriptional activator TRE: tetracycline response element

  8. RPE65: The retinal pigment epithelium-specific 65 kDa protein is located in the retinal pigment epithelium and is involved in the conversion of all-trans retinyl ester to 11-cis retinol during phototransduction, which is then used in visual pigment regeneration in photoreceptor cells.

  9. The ability of the Dox-regulatable system (Tet-OFF and Tet-ON) to regulate retinal function in RPE65-deficient dogs??

  10. transactivator Results and Methods cDNA promoter promoter A1 to A3 transactivator promoter promoter cDNA A4 and A5 A6

  11. Subretinal Injection • http://www.jove.com/video/4286/subretinal-injection-gene-therapy-vectors-stem-cells-perinatal-mouse

  12. AAV2/4TetOff.rpe65 (A2) AAV2/4TetOn.rpe65 (A4) CT CT 6mpi 6mpi Zone of the bleb AAV2/4CMV.rpe65 (A6) OCT scanning path CT 6mpi Retinal vessel Fundus photography Optical coherence tomography (OCT) image

  13. immunogenicity AAV2/4TetOff.rpe65 (A2) AAV2/4TetOn.rpe65 (A4) AAV2/4CMV.rpe65 (A6) Mac: macaque, positive control

  14. Electroretinography (ERG) • measures the electrical responses of various cell types in the retina, including the photoreceptors (rods and cones), inner retinal cells (bipolar and amacrine cells), and the ganglion cells. • If a flash ERG is performed on a dark-adapted eye, the response is primarily from the rod system. • Flash ERGs performed on a light-adapted eye will reflect the activity of the cone system. • Sufficiently bright flashes will elicit ERGs containing an a-wave (initial negative deflection) followed by a b-wave (positive deflection).

  15. Sibling of RP patient RP patient

  16. Right eye Left eye

  17. ERG Recording of TetOff Vector Treated Dogs

  18. AAV2/4TetOff.rpe65 in RPE65-deficient dogs treated eye A1: Volume: 600ul untreated eye A2: Volume: 350ul A3: Volume: 590ul

  19. ERG Recording of TetOn Vector Treated Dogs

  20. AAV2/4TetOn.rpe65 in RPE65-deficient dogs A4: Volume: 540ul treated eye untreated eye A5: Volume: 460ul

  21. Evaluation of Visual Function of A6, 3mpi and 6mpi

  22. Evaluation of Visual Function of A1, 11mpi, ON2

  23. Conclusion • RPE65-deficient dogs treated with Dox-regulatable AAV vectors displayed retinal function recovery, but not rescue of vision. • Injection of constitutive vectors in RPE65-deficient dogs showed improvement of vision when the amplitude of the dark-adapted b-wave was above 60V.

  24. Questions • What is gene therapy? • What is Dox-regulatable system? • What is the difference between TetON and TetOFF? • What is the role of RPE65? • What is electroretinography (ERG)?

  25. How might one resolve the problem these authors encountered in improving vision in RPE65-deficient dogs?

More Related